Stockreport
CDC, public health labs have conducted at least 31,000 tests [MarketWatch]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
CDC, public health labs have conducted at least 31,000 tests At least 31,878? tests have been conducted for people suspected of having COVID-19, as of March 17, according to the most recent data provided by the Centers for Disease Control and Prevention (CDC). This includes specimens tested by public health laboratories (27,623) and by the CDC (4,255). That's up from Tuesday's tally of 25,162 COVID-19 tests. That said, the jump in test counts doesn't mean that more than 6,000 tests were conducted Tuesday. The tally could include lag times, the CDC has said. However, now that large diagnostics makers like Hologic Inc. HOLX, -10.74% , Roche Holding ROG, -1.35% and Thermo Fisher Scientific Inc. TMO, -3.50% have received emergency use authorization from the Food and Drug Administration to begin COVID-19 testing, case counts in the U.S. are expected to significantly increase. There are currently 6,510 confirmed cases of COVID-19 in the U.S.; 114 people in 18 states have died.
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration[Business Wire]
- Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance][Yahoo! Finance]
- New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA[Business Wire]
- $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOLX, MOFG, NIC, and AWK[PR Newswire]
- Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $79.00 price target on the stock.[MarketBeat]
- More
HOLX
SEC Filings
SEC Filings
- 12/12/25 - Form PREM14A
- 11/18/25 - Form 4
- 11/18/25 - Form 4
- HOLX's page on the SEC website
- More